APEX MEDICAL COMPANY LTD. sold 124,000 shares of HANSOH PHARMA on the SEHK open market at an average of HKD 33.9623 per share on October 2, 2026, involving about HKD 4.21 million.
Prior to the disposal, APEX MEDICAL COMPANY LTD.'s long position in HANSOH PHARMA was 920.00 million shares, representing 15.17%; following the disposal, the holding changed to 919.88 million shares, with the long position ratio falling to 15.16%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.